UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
February 12, 2008
RESPONSE GENETICS, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 000-1124608 | | 11-3525548 |
(State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (IRS employer identification no.) |
1640 Marengo St., 6th Floor
Los Angeles, California 90033
(323) 224-3900
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On February 12, 2008, the compensation committee of the board of directors (the “Compensation Committee”) of Response Genetics, Inc. (the “Company”) awarded bonuses to its named executive officers, based on their performances and their achievement of Company and individual goals for the year ended December 31, 2007, in the following amounts:
Executive Officer | | Amount of Bonus | |
| Kathleen Danenberg, President & Chief Executive Officer | | $ | 175,000 | |
| Thomas Stankovich, Vice President, Chief Financial Officer and Secretary | | $ | 80,000 | |
| James Clark, Vice President & Chief Operating Officer | | $ | 80,000 | |
| Denise McNairn, Vice President & General Counsel | | $ | 80,000 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | RESPONSE GENETICS, INC. |
| | | |
| | | |
| Dated: February 15, 2008 | By: | /s/ Kathleen Danenberg | |
| | | Kathleen Danenberg President & Chief Executive Officer |
